| |
StructureChemical NameCASMF
Fatty acids, dehydrated castor-oil, reaction products with bisphenol A-epichlorohydrin polymer and soya fatty acids 103069-83-6
Fatty acids, linseed-oil, polymers with glycerol, phthalic anhydride and rosin 103069-85-8
Fats and Glyceridic oils, vegetable, sulfated, sodium salts 103069-98-3
Siloxanes and Silicones, di-Me, di-Ph, polymers with Ph silsesquioxanes, methoxy-terminated, reaction products with adipic acid-diethylene glycol-isophthalic acid-trimethylolethane-trimethylolpropane polymer 103070-01-5
Siloxanes and Silicones, di-Me, methoxy Ph, polymers with Ph silsesquioxanes, methoxy-terminated, polymers with adipic acid, isophthalic acid and trimethylolpropane 103070-05-9
2,5-Furandione, polymer with 2,2-bis[(2-propenyloxy)methyl]-1-butanol, 2,2'-oxybis[ethanol] and 1,2-propanediol, 2-(2-butoxyethoxy)ethyl ester 103070-09-3
4,4,2,4-Ac-4Glu 103078-28-0
2-(1-hydroxyethyl)-5-(2-hydroxypropan-2-yl)cyclohex-2-en-1-ol 103079-06-7 C11H20O3
2-Methyl-4-dibenzylaminobenzaldehyde-1,1-diphenylhydrazone 103079-11-4 C34H31N3
(5Z)-7-[(1S,5R)-6,6-Dimethyl-3β-[(1-oxohexyl)amino]bicyclo[3.1.1]heptan-2α-yl]-5-heptenoic acid 103081-25-0
N-(6-(2-carboxy-4,6-dinitrophenylamino)hexanoyl)glucopyranosylamine 103083-55-2
Glycine, N-(3-pyridinylmethylene)- (9CI) 103084-32-8 C8H8N2O2
Glycine, N-(4-pyridinylmethylene)- (9CI) 103084-34-0 C8H8N2O2
5-Hexen-2-one, 3-hydroxy-3-methyl- (9CI) 103084-92-0 C7H12O2
1,2-bis(4-hydroxyphenyl)-3,4-dihydro-6-hydroxynaphthalene 103088-13-7
o-nitrophenylsulfenyl-lysyl-tryptophan 103088-69-3
5-chloroformycin A 103090-47-7
5'-chloro-2'-deoxyformycin A 103090-53-5
Isoxazole, 3-(3-thienyl)- (9CI) 103092-70-2 C7H5NOS
3-Ethyl-5-methyl-4-(2-chlorophenyl)-2-(2,2-diethoxy-ethoxymethyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate 103094-30-0 C24H32ClNO7
Toluene, 4-ethoxy-5-methoxy-2-nitro- (6CI) 103095-41-6 C10H13NO4
Toluene, 5-ethoxy-4-methoxy-2-nitro- (6CI) 103095-42-7 C10H13NO4
4-ETHOXY-5-METHOXY-2-NITROBENZOIC ACID 103095-48-3 C10H11NO6
DL-3-Amino-3-(2-methoxyphenyl)propionic acid 103095-63-2 C10H13NO3
5-(4-BROMOPHENYL)-2,4-DIHYDRO-3H-PYRAZOL-3-ONE 103095-74-5 C9H7BrN2O
ethyl 2-amino-4-methoxybenzoate 103096-05-5 C10H13NO3
1,3-Dioxolane-4-methanol,2-methyl-2-(2-pyridyl)-(6CI) 103096-07-7 C10H13NO3
Toluene, 3-ethoxy-4-methoxy-5-nitro- (6CI) 103096-21-5 C10H13NO4
1-Benzimidazoleacetamide,N-methyl-(6CI) 103096-30-6 C10H11N3O
1,3-BIS(DICYCLOHEXYLPHOSPHINO)PROPANE 103099-52-1 C27H50P2
Hexanedioic acid, polymer with 1,4-butanediol and 2,2-dimethyl-1,3-propanediol, 2-ethylhexyl ester 103101-14-0
(3-N-BOC-AMINO-2-OXO-2,3,4,5-TETRAHYDRO-BENZO[B]AZEPIN-1-YL)-ACETIC ACID 103105-97-1 C17H22N2O5
napyradiomycin C2 103106-19-0
napyradiomycin C1 103106-20-3
(3R)-3α-Chloro-6,8-dihydroxy-3,10a-dihydro-2,2-dimethyl-10aβ-[[(1R,3S)-2,2-dimethyl-3-chloro-6-methylenecyclohexyl]methyl]-2H-naphtho[2,3-b]pyran-5,10-dione 103106-21-4
3,4a-Dichloro-6,8-dihydroxy-3,4,4a,10a-tetrahydro-2,2-dimethyl-10a-[(2,2-dimethyl-3-bromo-6-methylenecyclohexyl)methyl]-2H-naphtho[2,3-b]pyran-5,10-dione 103106-22-5
napyradiomycin B1 103106-23-6
napyradiomycin A1 103106-24-7 C25H30Cl2O5
hydrophobic protein, transmissible gastroenteritis virus 103106-46-3
Fibroblast Growth Factor 2 103107-01-3
3-Hexenyltrimethylsilane 103110-63-0
FENCHLORAZOL-ETHYL 103112-35-2 C12H8Cl5N3O2
3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,12,12,13,13,14,14,15,15,16,16,16-Nonacosafluorohexadecane-1-thiol 103119-64-8
Phthalazine, 5-fluoro- (9CI) 103119-77-3 C8H5FN2
5-BROMOPHTHALAZINE 103119-78-4 C8H5BrN2
3-[8-[2-Cyano-4-(methylsulfonyl)phenylazo]-5-hydroxy-6-(propionylamino)-1-naphtylaminosulfonyl]-N-[5-hexadecyloxy-2-hydroxy-4-(1,1,3,3-tetramethylbutyl)phenyl]benzenesulfonamide 103122-63-0
[(2-Methylpropoxy)thioxomethyl]carbamic acid ethyl ester 103122-66-3
renin inhibitory peptide, R-PEP-27 103122-78-7
[[[(2R,3R,4R,5R)-5-(3-amino-5-oxo-4,7,9-triazabicyclo[4.3.0]nona-2,7,1 0-trien-9-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl]oxy -hydroxy-phosphoryl]oxyphosphonic acid 103122-85-6 C11H17N4O14P3
(3S)-3-[[2-[[2-[[(2S)-2-[[(2R)-2-amino-3-(1H-indol-3-yl)propanoyl]amin o]propanoyl]amino]acetyl]amino]acetyl]amino]-3-[[(1S)-1-carboxyethyl]c arbamoyl]propanoic acid 103122-89-0 C25H33N7O9
K-4011 103124-98-7
K-3827 103124-99-8
4,5-Dihydro-2-[2-(1-naphthalenyl)ethyl]-1H-imidazole 103125-00-4
K-4299 103125-01-5
K-4010 103125-02-6
(+)-CHLOROMETHYL MENTHYL ETHER 103128-76-3 C11H21ClO
Valine, 4-(methylthio)-, (R*,R*)- (9CI) 103129-21-1 C6H13NO2S
Valine, 4-(methylthio)-, (R*,S*)- (9CI) 103129-22-2 C6H13NO2S
BENAZEPRIL RELATED COMPOUND G (15 MG) ((3-(1 -ETHOXYCARBONYL-3-PHENYL-(1 S)-PROPYL)AMINO-2,3,4,5-TETRAHYDRO-2-OXO-1H-1-(3S)-BENZAZE-PINE)-1-ACETIC ACID, ETHYL ESTER) 103129-58-4 C26H32N2O5
d-Amlodipine 103129-81-3 C20H25ClN2O5
(S)-Amlodipine 103129-82-4 C20H25N2O5Cl
KINETENSIN 103131-69-7 C56H85N17O11
N-[4-(2-Hydroxy-3-phenoxypropoxy)phenyl]acetamide 103137-52-6
N-tert-butyloxycarbonyl-prolyl-alanyl-alanyl-methylamide 103137-93-5
N-tert-butyloxycarbonyl-prolyl-glycyl-alanyl-methylamide 103137-94-6
3,5,8-trimethylimidazo(4,5-f)quinoxalin-2-amine 103139-94-2
6-Quinoxalinamine,2,8-dimethyl-(9CI) 103139-95-3 C10 H11 N3
6-Quinoxalinamine,N,3,8-trimethyl-(9CI) 103139-97-5 C11 H13 N3
6-Quinoxalinamine,3,8-dimethyl-(9CI) 103139-99-7 C10 H11 N3
2-(3,5-DICHLOROPHENOXY)ACETONITRILE 103140-12-1 C8H5Cl2NO
2,3-Dihydroxy-4-[(2-hydroxy-4-methoxy-6-propylbenzoyl)oxy]-6-propylbenzoic acid methyl ester 103142-15-0
Ethanone, 1-[1-(2-methyl-2-propenyl)-2-pyrrolidinyl]-, (S)- (9CI) 103142-92-3 C10H17NO
Ethanone, 1-[1-(3,4,5,6-tetrahydro-2-pyridinyl)cyclopropyl]- (9CI) 103143-07-3 C10H15NO
Ethanone, 1-(2-methylthiiranyl)- (9CI) 103144-76-9 C5H8OS
Ethanone, 1-(3-methylthiiranyl)-, trans- (9CI) 103144-77-0 C5H8OS
N-CBZ-PRO-LEU-GLY HYDROXAMATE 103145-74-0 C21H30N4O6
4-[4-(Dimethylamino)-1-(4-fluorophenyl)-1-hydroxybutyl]-3-(hydroxymethyl)benzonitrile 103146-25-4 C20H23FN2O2
4-[4-(Dimethylamino)-1-(4-fluorophenyl)-1-hydroxybutyl]-3-(hydroxymethyl)benzonitrile hydrobromide 103146-26-5 C20H24BrFN2O2
Benzoic acid, 2-amino-4-(aminocarbonyl)-, ethyl ester (9CI) 103147-58-6 C10H12N2O3
Diphosphonopentaosylceramide 103147-89-3
3-(3,4-dihydroxyphenyl)-N-n-propylpiperidine 103150-17-0
2H-Benzimidazol-2-one,1,3-dihydro-4-(1-methylethyl)-(9CI) 103151-02-6 C10H12N2O
5-ISOPROPYL-1,3-DIHYDRO-BENZIMIDAZOL-2-ONE 103151-03-7 C10H12N2O
2-Benzimidazolinone,5-propyl-(6CI) 103151-04-8 C10H12N2O
(4,5-DIHYDRO-THIAZOL-2-YL)-(2-METHOXY-PHENYL)-AMINE 103151-15-1 C10H12N2OS
3-Heptylphenol 103151-49-1
Chloriertes Polybutadien, Gehalt an Tetrachlorkohlenstoff <=50 ppm und Gehalt an Toluol <=2,5 % und mittlere molare Masse 20.000-200.000 103170-23-6
Cellulose, 2-hydroxypropyl methyl ether, reaction products with glyoxal 103170-24-7
Cyclohexane, 5-isocyanato-1-(isocyanatomethyl)-1,3,3-trimethyl-, homopolymer, Me Et ketone oxime-blocked 103170-26-9
Formaldehyde, polymers with sulfonated methylated phenol, sodium salts 103170-27-0
Ilmenite (FeTiO3), reaction products with carbon monoxide 103170-28-1
Urea, polymers with formaldehyde and sulfonated methylated phenol, sodium salts 103170-33-8
Urea, polymers with formaldehyde, phenol and sulfonated methylated phenol, ammonium salts 103170-35-0
H-SER-PRO-SER-ASN-SER-LYS-CYS-PRO-ASP-GLY-PRO-ASP-CYS-PHE-VAL-GLY-LEU-MET-NH2 103170-36-1
oct-1-ene 103170-38-3 C10H20
ANATOXIN-A(S) 103170-78-1 C7H17N4O3P
carbaton 103171-42-2
collitine 103171-46-6
POLYGLYCERYL-10 HEPTAOLEATE 103175-09-3
Ethanone, 1-(2,3,5,6,7,8-hexahydro-1-indolizinyl)- (9CI) 103175-18-4 C10H15NO
452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 511 512 513 514 515 516 517 518 519 520 521 522 523 524 525 526 527 528 529 530 531 532 533 534 535 536 537 538 539 540 541 542 543 544 545 546 547 548 549 550 551 552 553 554 555 556 557 558 559 560 561 562 563 564 565 566 567 568 569 570 571 572 573 574 575 576 577 578 579 580 581 582 583 584 585 586 587 588 589 590 591 592 593 594 595 596 597 598 599 600 601 602 603 604 605 606 607 608 609 610 611 612